Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GOP Senators Author Latest Letter To Appropriators, Urge More Funds For FDA

This article was originally published in The Gray Sheet

Executive Summary

The new Republican lawmaker from Minnesota - Sen. Norm Coleman - is proving to be a strong ally of the medical device industry

You may also be interested in...

Medicare Reform Bills Head To Conference; Competitive Bidding Fuels Debate

AdvaMed will work closely with Sens. Rick Santorum (R-Penn.) and Blanche Lincoln (D-Ark.) to ensure language easing criteria for new technology "add-on" payments is included in the final Medicare bill

Prion Research Should Focus On Diagnostics, Infrastructure – IoM

Development of effective diagnostics and additional research infrastructure in the field of prion science, as well as expanding basic research, are highlighted as priority areas for the Department of Defense National Prion Research Program in an interim IoM report

What Lies Ahead: COVID-19 Vaccination Challenges

The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts